Publication
Urinary Biomarkers for Kidney Disease in ATTR Amyloidosis
dc.contributor.author | Rocha, A. | |
dc.contributor.author | Bravo, F. | |
dc.contributor.author | Beirão, I. | |
dc.contributor.author | Vizcaíno, J. | |
dc.contributor.author | Oliveira, J. | |
dc.contributor.author | Lobato, L. | |
dc.date.accessioned | 2015-01-07T19:07:33Z | |
dc.date.available | 2015-01-07T19:07:33Z | |
dc.date.issued | 2014 | |
dc.description.abstract | Aim: The detection and prognosis of nephropathy in transthyretin amyloidosis depends on albuminuria and renal function. Knowing that urinary levels of alpha-1 microglobulin and beta-2 microglobulin reflect tubular dysfunction while urinary alpha-2 macroglobulin implies glomerular damage, we decide investigate the diagnostic value of these markers in the patients with transthyretin amyloidosis. Methods: Serum and urinary samples collected from 30 patients and 11 asymptomatic carriers were tested for alpha-1 microglobulin, beta-2 microglobulin, alpha-2 macroglobulin, albumin, creatinine and cystatin C. Results: Pathological urinary alpha-1 microglobulin was detected in 17 patients, beta-2 microglobulin in 6 and alpha-2 macroglobulin in 5; 5 patients had albuminuria (mg/g creatinine) 30-300 and in 20 patients values >300 were present. Asymptomatic carriers did not present pathological excretion of these biomarkers and albuminuria was >30 in 1 individual. The excretion rates of alpha-1 microglobulin and beta-2 microglobulin were positively correlated with albuminuria (P<0.001), serum creatinine (P<0.05) and cystatin C (P<0.001). Urinary alpha-2 macroglobulin was almost exclusively found in the presence of albuminuria, although their levels do not correlate. Conclusion: Urinary biomarkers emerge as a potential approach to detect renal disease but unexpectedly, urinary alpha-2 macroglobulin was not a marker of the severity of albuminuria. | por |
dc.identifier.citation | Rocha A, Bravo F, Beirão I, Vizcaíno J, Oliveira JC, et al. (2014) Urinary Biomarkers for Kidney Disease in ATTR Amyloidosis. J Nephrol Ther 4: 181. doi:10.4172/2161-0959.1000181 | por |
dc.identifier.doi | 10.4172/2161-0959.1000181 | |
dc.identifier.uri | http://hdl.handle.net/10400.16/1732 | |
dc.language.iso | eng | por |
dc.peerreviewed | yes | por |
dc.publisher | OMICS Publishing Group | por |
dc.relation.publisherversion | http://omicsonline.org/open-access/urinary-biomarkers-for-kidney-disease-in-attr-amyloidosis-2161-0959.1000181.php?aid=32195 | por |
dc.subject | Transthyretin | por |
dc.subject | Amyloid | por |
dc.subject | Low molecular weight proteins | por |
dc.subject | Kidney | por |
dc.subject | Proximal tubules | por |
dc.title | Urinary Biomarkers for Kidney Disease in ATTR Amyloidosis | por |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.citation.title | Journal of Nephrology & Therapeutics | por |
rcaap.rights | openAccess | por |
rcaap.type | article | por |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- urinary-biomarkers-for-kidney-disease-in-attr-amyloidosis-2161-0959.1000181.pdf
- Size:
- 987.37 KB
- Format:
- Adobe Portable Document Format
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.35 KB
- Format:
- Item-specific license agreed upon to submission
- Description: